Animal Health Conference Worldwide 2025

>
Animal Health Conference Worldwide 2025

Animal Health Conference Worldwide

Delivered - Virtually

February 25, 2025

Welcome to the Animal Health Conference Worldwide. Join veterinarians and industry experts as they explore the latest advancements in animal health and welfare. Learn about innovative treatments and practices improving the well-being of animals globally. Attend virtually on February 25, 2025, and gain unparalleled insight into the future of animal healthcare

What is the size of the animal health industry?

The Animal Health Market was valued at $42.8 billion in 2023 and, according to Research Nester, is likely to reach $182 billion by 2036, demonstrating a CAGR of 11.8%. Animal health includes preserving and protecting animals from various diseases as well as providing required veterinarian treatments. It entails regular animal monitoring in order to present the spread of disease. It ensures food safety and protects the public from animal-borne diseases.

Why are expenditures on animal health rising?

The following are among the key factors driving growth in the animal health industry:

Increasing pet ownership and spending:   There has been a significant rise in pet adoption rates and pet ownership globally. For example, according to the American Pet Products Association, 67% of U.S. households owned a pet in 2019. Further, pets are increasingly seen as family members, driving owners to seek out more advanced healthcare options. Also, the growing popularity of pet insurance is making advanced veterinary care more accessible.

Rising prevalence of zoonotic diseases:   The increasing incidence of diseases that can be transmitted between animals and humans is driving demand for animal health products and preventive care. Also, increasing recognition of the interconnectedness between human, animal and environmental health is driving a more holistic approach to animal healthcare.

Growing demand for animal protein:   As global demand for meat, dairy and eggs increases, there is greater need for animal health products to ensure livestock health and food safety.

Better detection of animal diseases:   Over a ten-year span, the prevalence of diabetes detected in dogs has soared almost 81% and 17% in cats.

What are new methods for addressing animal health?

The following are among the advancements in animal health treatment:

Diagnostic advancements:   Point-of-care urine analysis technology can provide rapid on-site diagnostics while advanced imaging techniques like MRI and digital radiography allow for more thorough assessments.

Less traumatic surgery:   Minimally invasive surgical techniques reduce pain and recovery time. Laser surgery offers precision cutting with reduced bleeding and infection risk.

Better tissue repair:   Regenerative medicine approaches like stem cell therapy and platelet-rich plasma treatments aid tissue repair. Also, 3D printing enables custom prosthetics and implants for orthopedic conditions.

Enhanced pharmaceuticals:   Development of new vaccines, including those stable at high temperatures, expands disease prevention capabilities. Research into alternatives to antibiotics, such as antimicrobial peptides and nanotechnology-based treatments. Advancements in drug delivery systems, including nanotechnology applications.

Portfolio of digital health technologies:   Wearable devices allow continuous monitoring of vital signs and activity levels. Telehealth platforms enable remote consultations and monitoring. AI-powered predictive analytics help forecast potential health issues.

Genetic approaches:   Studies on immune system responses at the genetic level aim to develop more effective vaccines. Genetic modification techniques are being explored to create disease-resistant animals.

Where is money moving in the animal treatment industry?

A lot of money is moving around in the animal treatment industry. Below are some of the recent acquisitions and IPOs of animal health companies:

  • Zoetis is selling its medicated feed additive (MFA) product portfolio to Phibro Animal Health for $350 million. The deal includes over 37 product lines sold in about 80 countries and six manufacturing sites.
  • Patterson Companies announced two acquisitions for its Animal Health business. One was that National Veterinary Services Limited is acquiring Infusion Concepts in the UK. The other was that Animal Health International is acquiring assets of Mountain Vet Supply in Colorado.
  • Merck Animal Health completed its acquisition of Elanco’s aqua business, bolstering its position in the aquaculture industry.
  • Mars Petcare acquired Heska Corporation, a provider of veterinary diagnostic solutions, in June 2023.
  • Ceva Santé Animale acquired Scout Bio, a biotechnology firm specializing in advanced pet therapies, in January 2024.
  • Zhengye Biotechnology Holding, a Chinese provider of veterinary vaccines, is planning a $7 million IPO on the Nasdaq. The company increased its proposed share offering by 20% ahead of the IPO.
  • Inspire Veterinary Partners, which owns and operates 13 veterinary hospitals in 9 U.S. states, filed for an IPO. The company is looking to offer 1.6 million shares at $4.00 to $6.00 per share.

What Will You Learn About the Presenting Companies?

Each management team will discuss their company’s existing and forthcoming product offerings. They will apprise listeners of their addressable markets and expectations for payor profiles. They will inform us of their research and development efforts, proprietary technologies and patent portfolios. They will tell us about their business models including the extent of their collaborations, licensing strategies, distribution channels, manufacturing strategies, milestones and exit strategies.

Note: All times Pacific


9:30 am – Welcoming Remarks

Speaker:   David Wanetick, CEO, Davos in the Desert


9:35 am – Overview of Funding Trends and Exits in the Animal Health Industries

Speaker:   David Wanetick, CEO, Davos in the Desert


10:00 am – Torigen

Torigen provides veterinary immunotherapies for companion animals with cancer and autoimmune diseases. Their first product, VetiVax, is an autologous cancer immunotherapy that uses the patient’s own tumor cells to create a personalized treatment. With over 50% of pets over 10 years old dying from cancer and existing treatments often costly with side effects, VetiVax offers an innovative and accessible option for cancer care. This new treatment is gaining traction among veterinarians nationwide, providing new hope for pets and their owners.

Speaker:   Ashley Kalinauskas, CEO, Torigen


10:30 am – Five Ways to Optimize Veterinary Practice Profitability in 2025

This session is essential for veterinarians and their practice managers. In a ‘use it today’ manner,  Dr. Hauser will discuss strategies to retain and attract clients, enhance veterinary team engagement, and needed steps to elevate the role of credentialed veterinary technicians in practice. Practice leadership will discover missed service opportunities and methods to capture lost revenue.

Speaker:   Dr. Wendy Hauser, Founder & President, Peak Veterinary Consulting


11:15 am – SynNutra Equine

SynNutra Equine develops synergistic nutraceuticals to support equine health and optimize performance safely, without the use of drugs or withdrawal times. Each product is designed to address specific equine health challenges. Additionally, SynNutra Equine continues to identify and solve emerging equine health issues, ensuring that their solutions remain relevant and effective in an ever-evolving industry.

Speaker:   Edwin L. Simpson, DVM, Founder and Chief Executive Officer, SynNutra Equine


11:45 am – Coffee Break


12:00 Noon – The Mechanics of Selling Your Veterinary Practice

Don’t even think about selling your veterinary practice without listening to this hyper-practical session. The discussion will cover critical points that directly impact the proceeds from your transaction:

  • Optimum organizational structure
  • Forming the deal team
  • Importance of reliable financial reports
  • Deal process and due diligence
  • Components of Indications of Interest and Letters of Intent
  • Handling real estate and equipment leases
  • Differences in selling veterinary practices to operating companies versus private equity firms
  • When and how to communicate the impending transaction to employees and customers
  • Indemnities and escrows
  • Rollovers and earn-outs
  • Post-sale seller obligations

Speaker:   Mary E. Mongioi, Partner, Forchelli, Deegan Terrana


12:45 pm – Company Presentation

TBA


1:15 pm – Valuing Veterinary Practices

This session will provide crucial parameters for determining the value of your veterinary practice. The following are among the issues to be addressed:

  • How does revenue mix/payor breakdown impact valuation?
  • How does services mix (e.g., routine care versus urgent care) affect the valuation of your practice?

Speaker:   Dr. Sheila Fitzpatrick, Founder, VP Veterinary Advisors


2:00 pmLeveraging Veterinary Talent To Optimize Productivity and Create Sustainable Work Spaces

This session presents a case study of how veterinary technicians and veterinary assistants can be maximally leveraged to enhance patient care, while simultaneously boosting revenues.  Insight will also be shared relative to how tele-wellness services have spurred profitability for a multi-clinic operator.

Speaker:  Katie Cutter, DVM, DACVO, and CEO of BoosterPet


2:45 pm – Adjournment


Please check back for updates to the agenda. If you would like to nominate a company to present, please contact David Wanetick at dwanetick@davosinthedesert.us.

Register now to listen to presentations from industry leaders and innovators. Registration is free for members of Davos in the Desert. Non-members can register now for just $10. No refunds.

Secure your spot today and be part of shaping the future of animal health industry!

Loading…

Start typing and press Enter to search

Shopping Cart

No products in the cart.